Drug Treatment in Juvenile Depression ? Is St. John's Wort a Safe and Effective Alternative?
| Autor: | Günter Seelinger, Marcus Mannel |
|---|---|
| Rok vydání: | 2007 |
| Předmět: |
Drug
medicine.medical_specialty business.industry media_common.quotation_subject Therapeutic effect Psychiatry and Mental health Drug treatment Tolerability El Niño Pediatrics Perinatology and Child Health medicine Juvenile Observational study Psychiatry business Depression (differential diagnoses) media_common |
| Zdroj: | Child and Adolescent Mental Health. 12:143-149 |
| ISSN: | 1475-3588 1475-357X |
| Popis: | Analyses of juvenile depression studies with long established anti-depressants (tricyclic anti-depressants) have revealed discouragingly little benefit, while side effects have been profound. Modern anti-depressants like selective serotonin reuptake inhibitors seemed to solve part of this problem until they were found to be associated with an increased risk of suicidal attempts and ideation, hostile behaviour and self-harm, while meta-analyses have revealed only marginal therapeutic effects for the majority. Actually, no drug is unequivocally accepted as the gold-standard for young depressive patients. St. John's Wort (SJW) has been traditionally used in Europe to treat symptoms associated with juvenile depression. Close to 50 clinical studies performed over the last two decades have been presented as evidence that standardized SJW preparations are equally effective as synthetic anti-depressants in the treatment of mild to moderate depression in adults. Tolerability is excellent, but some relevant drug interactions have to be considered. Today, SJW is by far the most frequently prescribed medication for child and adolescent depression in Germany. Some pilot and observational studies from Germany, Canada and the US have delivered promising results. However, randomised controlled trials amongst this age group have yet to be carried out and are long overdue. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text